APOL1 and focal segmental glomerulosclerosis: Experimental evidence suggests that COVID-19 causes collapsing FSGS by increasing systemic inflammatory cytokines, which in turn synergistically increase the expression of pathogenic APOL1 renal risk variants in podocytes and glomerular endothelial cells.21